期刊文献+

环氧化酶-2抑制剂联合依托泊苷对肺癌细胞增殖凋亡的影响 被引量:1

The Effects of Nimesulide Combined with Etoposide on Lung Cancer Cell Proliferation and Apoptosis
暂未订购
导出
摘要 目的探讨环氧化酶2(COX2)抑制剂尼米舒利(NIM)与化疗药依托泊苷(VP16)联用对肺癌细胞增殖和凋亡的影响。方法培养人肺癌细胞A549:①NIM(25μmol/L)与VP16(2~32μg/mL)联合,MTT试验观察干预48h后细胞增殖变化及增殖抑制率;②分为对照组、NIM组(25μmol/L)、VP16组(8μg/mL)和NIM+VP16组,观察12h、24h及48h后A549细胞生长情况,描记生长曲线;流式细胞术检测干预48h后细胞凋亡率。结果①VP16能抑制肺癌A549细胞的增殖,且呈量效关系(r=-0.908,P<0.01),NIM与VP16联用后,抑增殖作用增强,二者有相加或协同作用;②NIM及VP16均可抑制A549细胞的生长,诱导凋亡,二者联用后作用增强。结论NIM与VP16联用可增强对肺癌细胞增殖的抑制和凋亡的诱导,二者具有协同抗肿瘤作用。 Objective To investigate the effects of cyclooxygenase-2 selective inhibitor nimesulide (NIM) combined with etoposide (VP-16) on cell proliferation and apoptosis in human lung cancer. Methods Human lung cancer A549 cells were incubated and the studies were done as follows: ①NIM (25μmol/L) combined with VP-16 (2-32μg/mL) coincubated with A549 cells for 48h, the cell proliferation status and proliferation inhibition rate were detected by MTT reduction assay. ②The cells were divided into control group, NIM (25/μmol/L) group, VP-16 (8μg/mL) group and NIM + VP-16 group. The cells growth activity was observed by growth curve as cells coincubated for 12h, 24h, 48h, and the cell apoptosis rate was analyzed by flow cytometry. Results ①VP-16 could inhibit A549 cells proliferation in a concentration dependent pattern, which was enhanced as combined with NIM. NIM and VP-16 acted in a synergistic or additive pattern. ②NIM and VP-16 could induce A549 cells apoptosis effectively and the antitumor effects were augmented as they combined. Conclusion NIM combined with VP-16 can enhance the effects of growth inhibition and apoptosis induction and they play a synergistic anti-tumor effect in lung cancer cell.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2005年第11期689-691,共3页 Cancer Research on Prevention and Treatment
关键词 肺癌 凋亡 增殖 环氧化酶-2 依托泊苷 Lung neoplasm Apoptosis Proliferation Cyclooxygenase 2 Etoposide
  • 相关文献

参考文献3

二级参考文献33

  • 1Wei Wang~1 Shu-Kui Qin~1 Bao-An Chen~2 Hui-Ying Chen~1 1 Chinese PLA Cancer Center,Chinese PLA 81 Hospital,Nanjing 210002,Jiangshu Province,China2 Affliliated Zhongda Hospital of Southeast University Medical College,Nanjing 210087,Jiangsu Province,China.Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma[J].World Journal of Gastroenterology,2001,7(5):702-705. 被引量:50
  • 2粟俭,甄永苏,戚长菁,陈文君.真菌产生的新核苷转运抑制剂增强药物的抗肿瘤活性[J].药学学报,1994,29(9):656-661. 被引量:15
  • 3倪建华,陈国强,朱军,仲豪杰,唐伟,李秀松,熊树民,沈志祥,陈赛娟,王振义,陈竺.氧化砷对白血病细胞内 PML/PML-RARα 蛋白的影响[J].中华血液学杂志,1997,18(1):32-34. 被引量:33
  • 4Peters GJ,Backus HH,Freemantle S,et al.Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism[].Biochimica et Biophysica Acta.2002
  • 5Chan TA.Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention[].The Lancet Oncology.2002
  • 6Li HL,Zhang HW,Chen DD,et al.JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells[].Acta Pharmacological Sinica.2002
  • 7Brennan MM,Lambkin HA,Sheehan CD,et al.Detection of high risk subtypes of human papillomavirus in cervix swabs: routine use of the Digene Hybrid Capture assay and polymerase chain reaction analysis[].British Journal of Biomedical Science.2001
  • 8Niikura T,Saegusa Y,Nishikawa T,et al.Titanium-alloy particles induced cyclooxygenase-2 in human macrophage-like cells in vitro[].Kobe Journal of Medical Sciences.2002
  • 9Guo QL,Wu MS,Chen Z.Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo[].Acta Pharmacological Sinica.2002
  • 10Liu XL,Chen K,Ye YP,et al.Glutathione antagonized cy-clophosphamide and acrolein-induced cytotoxicity of PC3 cells and immunosuppressive actions in mice[].Acta Pharmacological Sinica.1999

共引文献74

同被引文献19

  • 1张磊 ,李然伟 ,洪宝发 ,史立新 .塞来昔布对VX_2兔肾癌的抑制作用[J].解放军医学杂志,2005,30(12):1086-1087. 被引量:3
  • 2方立,刘修恒,罗洪波.肾细胞癌中COX-2与血管生成的相关性研究[J].武汉大学学报(医学版),2006,27(2):152-155. 被引量:6
  • 3王兴鹏.环氧合酶、脂氧合酶与肿瘤,2006版.上海:第二军医大学出版社,2006.
  • 4Robert J. Motzer, Neeraj Agarwal, et al. NCCN Clinical Practice Guidelines in Kidney Cancer. V. 1. 2009.
  • 5Yoshimura R , Matsuyama M, Kawahito Y,et al . The effects of cyclooxygenase - 2 inhibitors on urological cancer cells. Int J Mol Med , 2004 ,13(6) :789.
  • 6Brian, Vivian. Maximal COX - 2 Immunostaining and Clinical Response to Celecoxib and Interferon Alpha Therapy in Metas atic Renal Cell Carcinoma. American Cancer Society 20 Deeember,2005:566 - 574.
  • 7Hokkaido G,Shinohara K. Combination therapy of meloxicam, a COX -2 inhibitor, and inlerferon- alfa in metastatic renal cell rarcinoma. 2008 Genitourinary Cancers Symposium.
  • 8Shuji Yoshino, Tadashi Okabe. Advanced renal cell carcinoma in which a combination of IFN - a and meloxicam was thought to be effective . Intenmtional Journal of Urology, (2003) 10,52-55.
  • 9Manabu, Yasuhisa. Favorable response to combination treatment of cimetidine, eyclooxygenase- 2 inhibitor and renin- angiotensin system inhibitor in metastatic renal cell carcinoma: Report of three eases. International Journal of Urology (2008) 15, 848 - 850.
  • 10Marnett LJ. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res, 1992 ,52:5575 - 5589.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部